发明名称 |
TREATMENT FOR SELECTIVE WEIGHT CONTROL |
摘要 |
<p>TREATMENT FOR SELECTIVE WEIGHT CONTROL A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.</p> |
申请公布号 |
CA1228026(A) |
申请公布日期 |
1987.10.13 |
申请号 |
CA19830442630 |
申请日期 |
1983.12.06 |
申请人 |
GREENWAY, FRANK L., III;BRAY, GEORGE A. |
发明人 |
GREENWAY, FRANK L., III;BRAY, GEORGE A. |
分类号 |
A61K8/41;A61K8/49;A61K9/00;A61K31/13;A61K31/135;A61K31/35;A61K31/352;A61K31/357;A61K31/41;A61K31/415;A61K31/435;A61K31/475;A61K31/48;A61K31/495;A61K31/52;A61K45/00;A61K47/00;A61P3/06;A61Q19/06;C07D233/24;C07D311/74;C07D319/20;C07D459/00;C07D473/08;C07D519/02;(IPC1-7):A61K31/48;A61K31/245 |
主分类号 |
A61K8/41 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|